Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 65/100

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

Wednesday, October 23, 2024 1 min read
Key Takeaway: Elutia Inc. has announced that Dr. Randy Mills, the President and CEO, will present at the LD Micro Main Event XVII Conference in Los Angeles on October 30, 2024. During the conference, Elutia management will also engage in individual meetings with institutional investors. The company specializes in drug-eluting biomatrix products aimed at enhancing the compatibility of medical devices for patients. This participation underscores Elutia's commitment to expanding its reach and connecting with potential investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia is presenting at a significant investor conference, which indicates growth opportunities.
  • The participation in 1x1 meetings suggests strong investor interest and engagement.
  • Elutia's focus on improving patient outcomes through innovative products reflects a commitment to humanistic medicine.

Full Press Release Details

SILVER SPRING, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a leader in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro Main Event XVII Conference in Los Angeles on Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET).
LD Micro Main Event XVII Conference
Presentation Date: Wednesday, October 30, 2024
Presentation Time: 2:00 p.m. PT (5:00 p.m. ET)
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro representative or email IR@elutia.com.
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com

Frequently Asked Questions

When is Elutia's presentation at LD Micro Main Event XVII?

Elutia's presentation is scheduled for October 30, 2024, at 2:00 p.m. PT.

Who will present for Elutia at the conference?

Dr. Randy Mills, President and CEO of Elutia, will present at the conference.

How can investors schedule meetings with Elutia's management?

Investors can schedule meetings by contacting an LD Micro representative or emailing IR@elutia.com.

What products does Elutia develop?

Elutia specializes in drug-eluting biomatrix products for medical devices.

What is Elutia's mission?

Elutia aims to humanize medicine, helping patients thrive with implantable technologies.

Tags: ELUT Viatris Investor Conferences Healthcare Elutia drug-eluting biomatrix investor conference LD Micro medical devices
Last updated: Oct 23, 2024